| pubmed-article:7509384 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7509384 | lifeskim:mentions | umls-concept:C0153594 | lld:lifeskim |
| pubmed-article:7509384 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:7509384 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:7509384 | lifeskim:mentions | umls-concept:C1511726 | lld:lifeskim |
| pubmed-article:7509384 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:7509384 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:7509384 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7509384 | pubmed:dateCreated | 1994-3-25 | lld:pubmed |
| pubmed-article:7509384 | pubmed:abstractText | To determine to what extent the benefits of cisplatin-based combination chemotherapy have been disseminated to all American men diagnosed with advanced testicular cancer. | lld:pubmed |
| pubmed-article:7509384 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7509384 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7509384 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7509384 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7509384 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7509384 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7509384 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7509384 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:7509384 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:7509384 | pubmed:author | pubmed-author:BoslG JGJ | lld:pubmed |
| pubmed-article:7509384 | pubmed:author | pubmed-author:KramerB SBS | lld:pubmed |
| pubmed-article:7509384 | pubmed:author | pubmed-author:FeuerE JEJ | lld:pubmed |
| pubmed-article:7509384 | pubmed:author | pubmed-author:CunninghamJ... | lld:pubmed |
| pubmed-article:7509384 | pubmed:author | pubmed-author:GellerN LNL | lld:pubmed |
| pubmed-article:7509384 | pubmed:author | pubmed-author:NayfieldS GSG | lld:pubmed |
| pubmed-article:7509384 | pubmed:author | pubmed-author:FreyC MCM | lld:pubmed |
| pubmed-article:7509384 | pubmed:author | pubmed-author:BrawleyO WOW | lld:pubmed |
| pubmed-article:7509384 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7509384 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:7509384 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7509384 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7509384 | pubmed:pagination | 368-77 | lld:pubmed |
| pubmed-article:7509384 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:meshHeading | pubmed-meshheading:7509384-... | lld:pubmed |
| pubmed-article:7509384 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7509384 | pubmed:articleTitle | After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer. | lld:pubmed |
| pubmed-article:7509384 | pubmed:affiliation | Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD 20892. | lld:pubmed |
| pubmed-article:7509384 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7509384 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7509384 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7509384 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7509384 | lld:pubmed |
